MOLECULE HOLDINGS (ERV2) — Financial Flexibility Index
Latest as of October 2022:
-0.14x
MOLECULE HOLDINGS (ERV2) has a Financial Flexibility Index of -0.14x as of October 2022. Free cash flow of €-1.10 Million (operating CF €-1.13 Million minus capex €33.11K) represents 0% of total liabilities (€7.61 Million).
Financial Flexibility Index
-0.14x
Free Cash Flow / Total Liabilities
Free Cash Flow
€-1.10 Million
Operating CF − Capex
Total Liabilities
€7.61 Million
EUR
Capital Expenditures
€33.11K
EUR
MOLECULE HOLDINGS Financial Flexibility Index (2021–2022)
Historical Financial Flexibility Index trend for MOLECULE HOLDINGS across 2 annual periods. See working capital to net assets of MOLECULE HOLDINGS to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for MOLECULE HOLDINGS (2021–2022)
Year-by-year free cash flow to debt coverage for MOLECULE HOLDINGS. For the full company profile including market capitalisation, see ERV2 company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | -0.14x | €-1.10 Million | €-1.13 Million | €7.61 Million | ▲ +72.6% |
| 2021 | -0.53x | €-2.79 Million | €-2.87 Million | €5.32 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities